ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619321 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619321; 2) Community: the network communities that were significantly associated with the response to NSC 619321; 3) Molecule: the relationships between components within communities and NSC 619321; 4) MDR: the compounds that were significantly associated with the NSC 619321.

NSC Compound Enrichment Correlation
NSC 77556 KC 1275 0.00138064329694955 0.081945267
NSC 717147 Null 0.00181889981954877 0.10165822
NSC 113943 6-Bromosangivamycin 0.00181889981954878 -0.10108286
NSC 343499 CI-921: amsacrine derivative 0.00204446620781765 0.203927
NSC 610457 Camptothecin Derivative 0.00204446620781765 0.22215204
NSC 357704 Cyanomorpholinodoxorubicin 0.00220234298765534 0.35571614
NSC 637220 cis-Difluorobis(1-phenylhexane-1,3-dionato)titanium(IV) 0.00220234298765537 0.19355711
NSC 728091 6-[(3-Hydroxy)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8,9-methy lenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.00220234298765537 -0.01635279
NSC 740975 6-(3-Chloropropyl)-9-cyano-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.00220234298765537 0.22612756
NSC 679005 2-Butenedioic acid, 2,2'-(2,4-dioxopyrimidine-1,3-diyl)bis-, tetraethyl ester 0.00298819091754573 -0.2881374
Total:44  Current:4    [First] [Prev] [Next] [Last]